- •Corneal Disease
- •Preface
- •Contents
- •Contributors
- •Core Messages
- •Organisms
- •Detection
- •Acid Fast Smears
- •Culture Media
- •Molecular Tests
- •Nucleic Acid Hybridization Probes
- •Line Probes
- •DNA Sequencing
- •FISH (Fluorescent In Situ Hybridization) Assay
- •DNA Microarray
- •Pulse Field Gel Electrophoresis (PFGE)
- •Management
- •Clinical Diagnosis
- •Medical Therapy
- •Surgical Intervention
- •Penetrating Keratoplasty
- •Corneal Cross-Linking
- •Summary for the Clinician
- •References
- •Core Messages
- •Introduction
- •Epidemiology
- •Visual Morbidity
- •Documentation
- •Causative Factors
- •Causative Bacteria
- •Investigation of Keratitis
- •Laboratory Diagnosis: Susceptibility Testing
- •Susceptibility and Resistance of Bacterial Isolates
- •Treatment: Antimicrobials
- •Current Antimicrobials in Use
- •The Fluoroquinolones
- •Aminoglycosides
- •Cephalosporins
- •Other Antimicrobials Used
- •Development of Existing and New Classes of Drugs
- •Tigecycline
- •Linezolid
- •Meropenem
- •Combination Therapy
- •Drug Delivery to the Cornea
- •Novel Methods of Drug Delivery to the Cornea
- •Conclusion
- •References
- •3: Heredity of Keratoconus
- •Introduction
- •Is Keratoconus a Heritable or Genetic Disease?
- •Mutational Screening of Candidate Genes in Keratoconus
- •Visual System Homeobox Gene 1 (VSX1)
- •Superoxide Dismutase 1 (SOD1)
- •Interleukin 1 (IL1) Superfamily
- •Collagen Genes
- •Genetic Mapping in Keratoconus
- •Genetics of Keratoconus – Mendelian or Complex?
- •References
- •4: Advance in Corneal Imaging
- •Introduction
- •In Vivo Confocal Microscopy (IVCM)
- •Principles of Confocal Microscopy
- •The Normal Cornea
- •Clinical Applications
- •Infectious Keratitis
- •Corneal Dystrophies
- •Refractive Surgery
- •Corneal Surgery
- •Other Clinical Applications
- •Limitations of IVCM
- •Anterior Segment Ocular Coherence Tomography (OCT)
- •Clinical Applications
- •Corneal Thickness Assessment
- •Refractive Surgery
- •Corneal Grafts
- •Limitations
- •Conclusion
- •References
- •Core Messages
- •Introduction
- •“Angiogenic Privilege of the Cornea” or “How Does the Normal Corneal Maintain Its Avascularity?”
- •General Mechanisms
- •Corneal Hemangiogenesis After Low-Risk Keratoplasty
- •Corneal Hemangiogenesis After High-Risk Keratoplasty
- •Corneal Lymphangiogenesis: Essential for Corneal Graft Rejection
- •Corneal Lymphangiogenesis in Dry Eye
- •Imaging of Corneal Lymphatic Vessels
- •Novel Anti(lymph)Angiogenic Treatment Options at the Cornea
- •Current Treatment Options for Immature Corneal (Blood and Lymphatic) Vessels
- •Steroids
- •Anti-VEGFs (Bevazicumab, Ranibuzumab, Pegaptanib, VEGF Trap)
- •Anti-IRS 1-Strategies (Antisense Oligonucleotides Against IRS 1)
- •Treatment Options for Mature Corneal Vessels
- •Unmet Needs and Future Directions
- •References
- •Core Messages
- •Introduction
- •Retrieval of Donor Tissue
- •Technical Aspects
- •Microbiological Aspects
- •Tissue Evaluation Aspects
- •Corneal Storage
- •Moist Chamber Storage of the Donor Eye
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Hypothermic Storage of the Corneoscleral Button
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Organ Culture (Normothermic Storage) of the Corneoscleral Button
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Other Aspects
- •Pre-cutting of Corneal Tissue for Endothelial Keratoplasty (EK)
- •Microkeratome Cutting
- •Femtosecond Laser Cutting
- •Stripping of Descemet’s Membrane with Endothelium
- •Donor Considerations for EK
- •References
- •7: Infant Keratoplasty
- •Core Messages
- •Introduction
- •Indications for Surgery
- •Visual Outcome
- •Patient Selection
- •Patient Assessment
- •Ancillary Testing
- •Donor Tissue
- •Intraoperative Considerations
- •Concurrent Surgical Procedures
- •Postoperative Considerations
- •Suture Management
- •Optical Correction and Amblyopia Therapy
- •Postoperative Complications
- •Glaucoma
- •Graft Rejection
- •Graft Failure
- •Alternatives to Penetrating Keratoplasty
- •Conclusion
- •References
- •Index
6 Storage of Donor Cornea for Penetrating and Lamellar Transplantation |
95 |
|
|
These rates have been decreasing over the last decade and this has been ascribed to improved eye banking procedures. However, surgeons need to be made aware of the microbiological condition of the received donor tissue. This may include information regarding the risk of tissue contamination, the decontamination steps and measures taken during processing, the storage procedure, the antibiotics that may have been used and the results of any microbiological tests that may have been performed (see section on corneal storage).
Tissue Evaluation Aspects
Enucleation allows for a more extensive anterior segment evaluation by a slit lamp, while examination in situ examination is often limited by the use of a penlight. This examination is important to determine if there has been previous anterior segment surgery or if there is any pathology of the eye that may not have been identified through the donor screening process. However, the examination of the excised cornea in the eye bank laboratory is possible by the slit lamp. The endothelium is the primary layer responsible for the maintenance of corneal hydration and transparency. Tests to assess the functional capacity of the endothelium cannot be applied during eye banking as they affect corneal viability. Therefore, one has to rely on the morphology of the endothelium to reflect its functional reserve and routine inspection of the endothelium is nowadays part of the donor evaluation. Assessment of the cornea by biomicroscopy of the endothelium also provides a quantifiable means of determining suitability for use and helps to increase the donor supply by objectively assessing corneas that may otherwise be arbitrarily excluded for transplantation beforehand on the basis of, for example, age or post-mortem time. While studies linking graft outcome with morphometric parameters of the endothelium are lacking, models to calculate cell loss over extended periods after penetrating keratoplasty have been presented [7, 8]. They provide a rationale for accepting a minimum donor cell density. Many eye banks consider about 2,000 cells/mm2 to be a minimum in cases of where transplantation of the endothelium is involved. In addition, an endothelial layer with considerable polymegathism or pleomorphism and/or the presence of guttae is considered indicative of a cornea that may be functionally deficient or compromised [9]. Ultimately, however, the final decision regarding use rests with the surgeon for each individual patient transplant procedure undertaken while taking the Eye Bank’s evaluation report into account.
Corneal Storage
For the whole eye, the most common storage method is moistened pot or moist chamber storage at 2–6°C, introduced in 1937 [1]. Today this technique is usually a temporary holding or transport method that precedes corneoscleral button excision.
Today the prevailing storage methods are those of placing the corneoscleral button in a modified tissue culture medium. The cornea is then stored hypothermically at 2–6°C, a method introduced in 1974 by Mc Carey and Kaufman, or
